CHEBI:67002 - β-D-Galp-(1→3)-[β-Neup5Ac-(2→6)]-α-D-GalpNAc

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name β-D-Galp-(1→3)-[β-Neup5Ac-(2→6)]-α-D-GalpNAc
ChEBI ID CHEBI:67002
ChEBI ASCII Name beta-D-Galp-(1->3)-[beta-Neup5Ac-(2->6)]-alpha-D-GalpNAc
Definition A branched amino trisaccharide that consists of N-acetyl-α-D-galactosamine having a β-D-galactosyl residue attached at the 3-position and a β-N-acetylneuraminosyl residue attached at the 6-position.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C25H42N2O19
Net Charge 0
Average Mass 674.60300
Monoisotopic Mass 674.23818
InChI InChI=1S/C25H42N2O19/c1-7(30)26-13-9(32)3-25(24(40)41,46-21(13)15(34)10(33)4-28)42-6-12-17(36)20(14(22(39)43-12)27-8(2)31)45-23-19(38)18(37)16(35)11(5-29)44-23/h9-23,28-29,32-39H,3-6H2,1-2H3,(H,26,30)(H,27,31)(H,40,41)/t9-,10+,11+,12+,13+,14+,15+,16-,17-,18-,19+,20+,21+,22-,23-,25-/m0/s1
InChIKey WGMXQFVVADPLGR-IXQOGYPSSA-N
SMILES [H][C@]1(O[C@](C[C@H](O)[C@H]1NC(C)=O)(OC[C@H]1O[C@H](O)[C@H](NC(C)=O)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H]1O)C(O)=O)[C@H](O)[C@H](O)CO
Roles Classification
Biological Role(s): epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing β-D-Galp-(1→3)-[β-Neup5Ac-(2→6)]-α-D-GalpNAc (CHEBI:67002) has role epitope (CHEBI:53000)
β-D-Galp-(1→3)-[β-Neup5Ac-(2→6)]-α-D-GalpNAc (CHEBI:67002) is a amino trisaccharide (CHEBI:59266)
β-D-Galp-(1→3)-[β-Neup5Ac-(2→6)]-α-D-GalpNAc (CHEBI:67002) is a galactosamine oligosaccharide (CHEBI:22484)
IUPAC Name
5-acetamido-3,5-dideoxy-D-glycero-β-D-galacto-non-2-ulopyranonosyl-(2→6)-[β-D-galactopyranosyl-(1→3)]-2-acetamido-2-deoxy-α-D-galactopyranose
Synonyms Sources
β-D-Gal-(1→3)-[β-Neu5Ac-(2→6)]-α-D-GalNAc ChEBI
β-D-galactosyl-(1→3)-[β-N-acetylneuraminosyl-(2→6)]-N-acetyl-α-D-galactosamine ChEBI
β-N-acetylneuraminosyl-(2→6)-[β-D-galactosyl-(1→3)]-N-acetyl-α-D-galactosamine ChEBI
β-Neu5Ac-(2→6)-[β-D-Gal-(1→3)]-α-D-GalNAc ChEBI
β-Neup5Ac-(2→6)-[β-D-Galp-(1→3)]-α-D-GalpNAc ChEBI
Galβ1-3(Neu5Acβ2-6)GalNAcα ChEBI
Galβ1→3(Neu5Acβ2→6)GalNAcα ChEBI
Neu5Acb2-6(Galb1-3)GalNAca ChEBI
Neu5Acβ2-6(Galβ1-3)GalNAcα ChEBI
O-5-(acetylamino)-3,5-dideoxy-D-glycero-β-D-galacto-2-nonulopyranonosyl-(2→6)-O-[β-D-galactopyranosyl-(1→3)]-2-(acetylamino)-2-deoxy-α-D-galactopyranose ChEBI
WURCS=2.0/3,3,2/[a2112h-1a_1-5_2*NCC/3=O][a2112h-1b_1-5][Aad21122h-2b_2-6_5*NCC/3=O]/1-2-3/a3-b1_a6-c2 GlyTouCan
Manual Xrefs Databases
G64050LH GlyTouCan
G64050LH GlyGen
View more database links
Citations Waiting for Citations Types Sources
19443021 PubMed citation Europe PMC
19695255 PubMed citation Europe PMC
25568069 PubMed citation Europe PMC
31537530 PubMed citation Europe PMC
36988069 PubMed citation Europe PMC
Last Modified
03 May 2023